Metropolitan Life Insurance Company (MetLife)’s Medallia, Inc. MDLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,828
Closed -$164K 2891
2021
Q3
$164K Sell
4,828
-64
-1% -$2.14K ﹤0.01% 2226
2021
Q2
$165K Sell
4,892
-1,588
-25% -$45.6K ﹤0.01% 2288
2021
Q1
$181K Sell
6,480
-140
-2% -$5.2K ﹤0.01% 2088
2020
Q4
$220K Buy
6,620
+144
+2% +$4.59K ﹤0.01% 1874
2020
Q3
$178K Sell
6,476
-29
-0.4% -$880 ﹤0.01% 1844
2020
Q2
$164K Buy
6,505
+2,339
+56% +$55.8K ﹤0.01% 1937
2020
Q1
$83.5K Buy
4,166
+3,146
+308% +$84.6K ﹤0.01% 2145
2019
Q4
$31.7K Buy
1,020
+17
+2% +$502 ﹤0.01% 2506
2019
Q3
$27.5K Buy
+1,003
New +$35.6K ﹤0.01% 2538

Metropolitan Life Insurance Company (MetLife)'s MDLA Position: Q4 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Medallia, Inc. (MDLA) in Q4 2021, closing a stake of 4,828 shares — an estimated $164K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MDLA in Q3 2019 and held it in 9 quarters. The position peaked at $220K in Q4 2020. 0 funds tracked by Wall St. Rank hold MDLA as of Q4 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Medallia, Inc. position as of Q4 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,828 Medallia, Inc. shares in Q4 2021, an estimated $164K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Medallia, Inc. in Q3 2019 and held it in 9 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Medallia, Inc. position peaked at $220K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Medallia, Inc. as of Q4 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.